NCT05876767View on ClinicalTrials.gov

Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions
Healthy Volunteer
Interventions
DRUG

SAR444336

Single or repeated dose subcutaneous injection

DRUG

Placebo

Single or repeated dose subcutaneous injection

Trial Locations (2)

2333 CL

Investigational Site Number :5280001, Leiden

9728 NZ

Investigational Site Number :5280002, Groningen

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05876767 - Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter